Abbott to acquire Cephea Valve Technologies, Inc.
Abbott (NYSE: ABT) announced today that it has exercised its option to purchase Cephea Valve Technologies, Inc., a privately held medical device company developing a less-invasive heart valve replacement technology for people with mitral valve disease. Financial terms were not disclosed. Abbott provided capital and secured an option to purchase Cephea in 2015.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Abbott Business and Industry Source Type: news
More News: Cardiology | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Medical Devices | Pharmaceuticals